Diabeloop SAS

[ Editor's Note: A version of this article originally appeared in In Vivo on 11 August .] Investment activity in biopharma, healthtech, diagnostics and medtech in the first half of 2022 had to be

Investment activity in biopharma, healthtech, diagnostics and tools and medtech in the first half of 2022 had to be assessed against the backdrop of a volatile macro and economic environment. While Q1

[ Editor's Note: A version of this article originally appeared in In Vivo .] The annual MedTech Forum was back to its “in-person” best in May 2022, having adjusted to the pandemic needs over the p

The annual MedTech Forum was back to its “in-person” best in May 2022, having adjusted to the pandemic needs over the previous two years with virtual-only forums in 2020 and 2021. The 3-5 May meeting